Briacell Therapeutics Corp

NASDAQ BCTX

Download Data

Briacell Therapeutics Corp Price to Earnings Ratio (P/E) on June 03, 2024: -5.71

Briacell Therapeutics Corp Price to Earnings Ratio (P/E) is -5.71 on June 03, 2024, a -95.35% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.
  • Briacell Therapeutics Corp 52-week high Price to Earnings Ratio (P/E) is -2.64 on June 21, 2023, which is 53.86% above the current Price to Earnings Ratio (P/E).
  • Briacell Therapeutics Corp 52-week low Price to Earnings Ratio (P/E) is -10.15 on March 14, 2024, which is -77.62% below the current Price to Earnings Ratio (P/E).
  • Briacell Therapeutics Corp average Price to Earnings Ratio (P/E) for the last 52 weeks is -4.98.
NASDAQ: BCTX

Briacell Therapeutics Corp

CEO Dr. William V. Williams M.D.
IPO Date Feb. 24, 2021
Location Canada
Headquarters Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Employees 16
Sector Healthcare
Industry Biotechnology
Description

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Similar companies

DAWN

Day One Biopharmaceuticals Inc

NA

NA

HEPA

Hepion Pharmaceuticals Inc

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email